What is the recommended interval for repeating a Cologuard (multitarget stool DNA test) screening in an average-risk individual with a negative result?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cologuard Screening Interval After Negative Result

If your Cologuard test is negative, repeat screening in 3 years. 1, 2

Guideline-Based Recommendation

The multitarget stool DNA test (Cologuard) should be repeated every 3 years following a negative result in average-risk individuals. 1, 2, 3 This interval is endorsed by:

  • American Cancer Society 2
  • U.S. Multi-Society Task Force on Colorectal Cancer 1, 2, 3

Important Context About This Recommendation

The 3-year interval represents a qualified recommendation based on limited long-term data. 1 When the FDA first approved Cologuard in 2014, guidelines explicitly noted "there are limited data available to determine an appropriate interval between screening." 1 The 3-year interval was established based on the test's sensitivity characteristics and modeling studies rather than direct evidence of outcomes at different intervals. 1

Critical Implementation Requirements

You Must Commit to Regular Testing

  • Sporadic or one-time Cologuard testing is inadequate and makes stool-based screening a poor choice. 4
  • The 3-year interval must be maintained consistently to achieve mortality benefit. 4

All Positive Results Require Colonoscopy

  • Any positive Cologuard result mandates immediate follow-up colonoscopy to rule out colorectal cancer or advanced neoplasia. 4, 2
  • Cologuard has a 13% false-positive rate (87% specificity), meaning roughly 1 in 8 positive tests will be false alarms requiring colonoscopy anyway. 2

Age-Specific Guidance

Continue Screening Through Age 75

  • Repeat Cologuard every 3 years through age 75 if you are in good health with life expectancy greater than 10 years. 2

Ages 76-85: Selective Screening

  • Between ages 76-85, continue screening only if you have no prior screening history, good overall health, and life expectancy exceeding 10 years. 2

Stop Screening at Age 85

  • Discontinue all colorectal cancer screening after age 85 regardless of prior screening history, as harms outweigh benefits. 2

Comparison to Alternative Screening Options

Colonoscopy Provides Longer Protection

  • A negative colonoscopy provides 10 years of protection versus only 3 years for Cologuard. 2
  • Colonoscopy uniquely detects AND removes precancerous polyps during the same procedure, directly preventing cancer rather than merely detecting it. 2

Consider Switching to Colonoscopy

  • If you find the 3-year Cologuard interval burdensome, colonoscopy every 10 years is the other first-tier screening option with the strongest evidence for mortality reduction. 2, 3

Common Pitfall to Avoid

Do not extend the Cologuard interval beyond 3 years, even if you had a prior negative colonoscopy. While one study suggested that patients with a previous negative colonoscopy who then use Cologuard still detect advanced adenomas at reasonable rates (30% of positive tests), 5 the established guideline interval remains 3 years regardless of prior colonoscopy history. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fecal Immunochemical Test (FIT) Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

When is Cologuard (multitarget stool DNA test) preferred over colonoscopy for colon cancer screening?
What is the recommended screening interval for Cologuard (multitarget stool DNA test) in an average-risk adult over 50 with no family history of colorectal cancer?
At what age should a 38-year-old woman with no medical history or family history of cancer start screening for colon cancer?
At what age does colonoscopy screening typically start for a low-risk individual, such as a 45-year-old female with no high-risk factors, specifically for average-risk (average risk) individuals?
At what age should a 45-year-old woman with no family history (FH) of cancer start screening for colon cancer?
What type of tube and centrifugation timeframe is recommended for collecting blood for Platelet-Rich Fibrin (PRF)?
What is the initial test to evaluate for pulmonary embolism (PE) in a patient with suspected PE?
What is the best approach for managing decreased appetite in an 87-year-old patient with dementia, frailty, and polypharmacy, considering the potential use of Remeron (mirtazapine) and elder tonic?
How often should mupirocin ointment be applied for a patient with a bacterial skin infection?
What is the best approach to manage a geriatric patient's complex medication regimen, which includes treatments for depression, anxiety, hypothyroidism, osteoporosis, and constipation, while minimizing the risk of drug interactions and side effects?
What is the recommended approach for diagnosing and managing a suspected milk allergy in a pediatric patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.